Chicago Discovery Solutions is a technology development company, developing novel products and processes for pharmaceutical industry.
As a company, we are dedicated to finding solutions that facilitate discovery of innovative drugs and truly applicable 'Green Technologies' in the area of pharmaceutical research and manufacturing. We are dedicated to the promotion and production of less toxic, more environmentally benign, and sustainable solutions which are both profitable to industry and beneficial to society. We believe using green alternatives should not mean compromises. Read here to learn about the new technologies available now. Read more about our company and our team.
Our scientist's core strengths lie in organic and medicinal chemistry enabling us to help companies involved in drug discovery research.
We provide custom organic synthesis, contract research, and process development services. Learn more about other services we offer by reading here.The company also offers analytical method development and validation services for HPLC and GC methods to pharmaceutical intermediates and APIs. It provides its services in the manufacturing areas for new non- infringing route development for API and intermediates, multi step chiral synthesis, large-scale synthesis and column chromatography.
We also offer synthetic support to your medicinal chemistry program by preparing reference compounds, intermediates, and impurities. We are capable of conceiving new pharmacophores, generate and optimize new lead molecules for ADME and/or toxicity.
MCAT-53™has been commercially launched by Chicago Discovery Solutions. This catalyst is a game changing catalyst as it has been found useful in synthesizing several molecules of biological interest by C-H activated C-C coupling reactions in water instead of routinely used harmful solvents. See more Technical Highlights of MCAT-53TMhere.
NEWS: May 28, 2019; Chicago Discovery Solutions receives a US patent 10,300, 471 from US patent and Trademark office titled ‘Ruthenium Catalyzed Synthesis of Biaryl Compounds in Water’. The issuance of this patent comes as one of Chicago Discovery Solution’s ruthenium formato catalyst MCAT-53 has been applied for the synthesis of biaryl drug intermediates in water https://pubs.acs.org/doi/10.1021/acs.oprd.8b00141.